Community Pharmacists Behaviour During Covid-19

Overview

During the COVID-19 pandemic, governments issued movement restrictions and placed areas into quarantine to reduce the spread of the disease.Community pharmacists and their teams are a vital healthcare provider during the outbreak; they remain on the frontline of public health by serving as direct points of access for their patients. The retail pharmacists should provide public community, costumers and patients with right and trusted information about covid-19. They also should have role in awareness spreading regarding personnel safety and hygiene

Full Title of Study: “SURVEY of RETAIL PHARMACISTS KNOWLEDGE, ROLE & BEHAVIOR DURING COVID-19 VIRUS OUTBREAK”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: October 1, 2020

Detailed Description

The survey will enroll as many community pharmacists as possible in the survey portion of the study – The number of participates have no limitations, at least 50 participants.

The survey will be enrolled in online google form, face to face interview & semi-structured telephone interviews if possible.

The research procedures:

1. An online survey link will include questions regarding the impact of role and behavior of retail pharmacists during covid-19 outbreak.

2. Face to face and semi-structured interviews if possible: For those pharmacists who state that they would like to participate in an interview, a random sample will be contacted.

Inclusion Criteria:

1. Post graduated pharmacist.

2. Community pharmacists.

Exclusion Criteria:

1. under graduated students.

2. not pharmacist.

Clinical Trial Outcome Measures

Primary Measures

  • community pharmacists facing covid-19
    • Time Frame: 6 months
    • Evaluate the knowledge, role & behavior of retail pharmacists in facing covid-19 virus through the survey

Participating in This Clinical Trial

Inclusion Criteria

  • Post graduated pharmacist. Community pharmacists.

Exclusion Criteria

  • under graduated students. not pharmacist.

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • Damanhour University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Asser Ghoneim, phD, Principal Investigator, Professor in Pharmacology, Faculty of pharmacy, Damanhour University
  • Overall Contact(s)
    • Noha El Bassiouny, PhD, 045317617, dr_nosa0777@yahoo.com

References

Farooq A, Laato S, Islam AKMN. Impact of Online Information on Self-Isolation Intention During the COVID-19 Pandemic: Cross-Sectional Study. J Med Internet Res. 2020 May 6;22(5):e19128. doi: 10.2196/19128.

Bukhari N, Rasheed H, Nayyer B, Babar ZU. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020 Apr 20;13:8. doi: 10.1186/s40545-020-00210-w. eCollection 2020.

Rutter V, Chan AHY, Tuck C, Bader L, Babar ZU, Bates I. Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018. J Pharm Policy Pract. 2018 Apr 11;11:10. doi: 10.1186/s40545-018-0140-3. eCollection 2018.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.